Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Uniform Quality Standards for a Quarter of a Century

Published: Wednesday, February 27, 2013
Last Updated: Tuesday, February 26, 2013
Bookmark and Share
SCHOTT Tubing has been publishing technical delivery specifications for pharmaceutical tubing for 25 years.

The international technology group SCHOTT has been documenting and publishing technical terms of supply for its glass tubing for use in pharmaceutical applications for 25 years now.

In fact, SCHOTT became the first company in the industry to provide its customers with exact specifications of the most important product parameters in 1988.

Since then, the ongoing improvements that have been made to its special glass tubing used to produce vials, syringes, cartridges and ampoules have been anchored in its terms of supply and thus made visible for its customers.

SCHOTT constantly strives to make improvements that flow into its quality standards to accommodate changing market demands, the needs of its customers and its own goal of providing its customers with maximum benefits.

A revised version of its technical delivery specifications is published about every three years.

“At SCHOTT Tubing, we have been setting the standards on manufacturing glass tubing for 25 years with our technical terms of supply. This means we are committed to constantly improving our production process and offer our customers the highest possible transparency and quality assurance,” says Jürgen Achatz, Global Sales Director for Pharmaceutical Tubing at SCHOTT.

In addition to a description of the products in which all of the characteristics of relevance to its customers are defined in great detail, the technical delivery specifications also include precisely determined tolerance ranges.

SCHOTT’s delivery specifications differ from its competitors’ technical terms of delivery not only in terms of their vast depth of detail and clarity.

The company also subjects its specification to further review by the Federal Association of the German Glass Industry.

The specialized group “Primary Packaging” discusses and evaluates the company’s standards, whereby the results flow directly into the final version of the delivery specifications.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Combining Chemotherapy With Immune-Blocking Drug Could Stop Cancer Growing Back
Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people.
Researchers Pioneer Use of Capsules to Save Materials
Wax capsule delivery systems can simplify a wide range of chemistry transformations.
Photoredox Catalyst Unlocks New Pathways for Nickel Chemistry
Using a light-activated catalyst, researchers have unlocked a new pathway in nickel chemistry to construct carbon-oxygen (C-O) bonds that would be highly valuable to pharmaceutical and agrochemical industries.
Scientists Determine How Antibiotic Gains Cancer-Killing Sulfur Atoms
In a discovery with implications for future drug design scientists have shown an unprecedented mechanism for how a natural antibiotic with antitumor properties incorporates sulfur into its molecular structure, an essential ingredient of its antitumor activity.
Familiar Drugs May Block Ebola Virus Infection
A well-known class of molecules, many of which are already in use therapeutically, may be able to block the Ebola virus’s entry into cells and halt the disease in its tracks, according to researchers at the University of Illinois at Chicago.
New Extra ‘Sticky’ Microgel Could Revolutionise Bladder Cancer Treatment
Researchers have designed a new super-efficient way of delivering an anti-cancer drug which could extend and improve the quality of life for bladder cancer patients - and perhaps save lives.
Common Class of ‘Channel Blocking’ Drugs May Find a Role in Cancer Therapy
Discoveries in fruit flies prompt unusual treatment of patient with metastatic disease.
Common Medications Could Delay Brain Injury Recovery
Drugs used to treat common complaints could delay the recovery of brain injury patients according to research by University of East Anglia (UEA) and University of Aberdeen scientists, published today in Brain Injury.
Scientists Make Strides in Therapy Preventing Addiction Relapse
Single Injection of Drug Candidate Prevents Meth Relapse in Animal Models.
New Clot-Busting Treatments Target Number One Killer
Australian researchers funded by the National Heart Foundation are a step closer to a safer and more effective way to treat heart attack and stroke via nanotechnology.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!